Chief Scientific Officer
Quotient Sciences
Nottingham, England, United Kingdom
Andy is currently Chief Scientific Officer at Quotient Sciences responsible for a team of scientific and technical experts across both the UK and USA supporting our clients drug development programmes from preclinical formulation development through to commercial drug product manufacturing. After obtaining a pharmacy degree and PhD from the University of Nottingham he has worked in the pharmaceutical industry for over 20 years for organisations of all sizes – from start-up biotechs to large pharmaceutical companies. He has a passion for the application of advanced drug delivery technologies to address unmet clinical needs, particularly in the areas of protein and peptide drug delivery, solubility enhancement and controlled release. He is a member of the Academy of Pharmaceutical Scientists of Great Britain and is a fellow of the Controlled Release Society.
Disclosure information not submitted.
Emerging Trends for FIH Studies Over the Last 4 Years
Tuesday, November 11, 2025
3:00 PM - 3:15 PM CT